Discovery of <i>N</i>,4-Di(1<i>H</i>-pyrazol-4-yl)pyrimidin-2-amine-Derived CDK2 Inhibitors as Potential Anticancer Agents: Design, Synthesis, and Evaluation

Cyclin-dependent kinase 2 (CDK2) has been garnering considerable interest as a target to develop new cancer treatments and to ameliorate resistance to CDK4/6 inhibitors. However, a selective CDK2 inhibitor has yet to be clinically approved. With the desire to discover novel, potent, and selective CD...

תיאור מלא

מידע ביבליוגרפי

Principais autores:	Biruk Sintayehu Fanta, Jimma Lenjisa, Theodosia Teo, Lianmeng Kou, Laychiluh Mekonnen, Yuchao Yang, Sunita K. C. Basnet, Ramin Hassankhani, Matthew J. Sykes, Mingfeng Yu, Shudong Wang
פורמט:	Artigo
שפה:	Inglês
יצא לאור:	MDPI AG 2023-03-01
סדרה:	Molecules
נושאים:	CDK2 CDK2 inhibitor pyrazole <i>N</i>,4-di(1<i>H</i>-pyrazol-4-yl)pyrimidin-2-amine antiproliferative activity bioisosteric replacement
גישה מקוונת:	https://www.mdpi.com/1420-3049/28/7/2951
תגים:	הוספת תג אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!